COMPANY PROFILE
Company Overview
The company was founded in August 2012.
Company registered capital
The company serves its customers.
Jiangsu Qitian Gene Biotechnology Co., Ltd.
Founded in 2012, Qitian Gene specializes in the research and application of recombinase-aided isothermal nucleic acid amplification technology (commonly known as RAA technology), developing an innovative platform for rapid on-site molecular testing using RAA. The platform integrates sample-preparation techniques, nucleic acid detection technologies, and complementary instruments, offering a comprehensive molecular testing solution tailored to meet the demand for swift, on-the-spot analysis under all-weather field conditions. It effectively addresses critical challenges such as limited access to electricity and shortages of trained personnel in remote environments. As a specialized, niche, and innovative high-tech enterprise, Qitian Gene seamlessly combines raw material production, cutting-edge R&D, product design, and technology commercialization into one integrated operation.
After more than a decade of technological innovation and expertise accumulation, leveraging RAA technology, the company has successfully undertaken two major national projects: the "13th Five-Year Plan" National Key Project on Major Infectious Diseases and the Ministry of Science and Technology's flagship initiative, "Public Safety Risk Prevention, Control, and Emergency Technology Equipment." Both projects have already passed national acceptance tests and resulted in the development of two Class III medical device registration products and two Class I product filings—remarkable achievements that underscore the company's cutting-edge capabilities. In 2021, the company was selected to lead Wuxi City’s key technological research project aimed at tackling critical challenges in COVID-19 prevention and control. In 2023, it joined the National "14th Five-Year Plan" Key R&D Program focused on "Major Natural Disaster Prevention and Public Safety," while also taking charge of Wuxi City’s "Taihu Light" science and technology innovation project that same year. To support its advanced R&D and manufacturing capabilities, the company boasts state-of-the-art facilities, including a GMP-compliant production facility, an independent quality inspection laboratory, a dedicated R&D center, and an advanced instrument production line. Additionally, the company has achieved robust international certifications, including ISO13485 and ISO9001 for its quality management systems, and has earned prestigious accolades such as National High-Tech Enterprise status and Jiangsu Province’s recognition as a Specialized, Sophisticated, and Novel Small-to-Medium-Sized Enterprise.
Leading Player in On-Site Molecular Testing
Our vision is to become the leader in on-site molecular testing, driving industry advancement through exceptional R&D capabilities and innovative strength—while contributing to the protection of human life and safety.
Vision
Racing against time to safeguard lives and ensure safety.
Our mission is to dedicate ourselves to innovating and developing a biosafety control system that is "more accurate, faster, and more convenient," continuously advancing molecular detection technologies and driving product innovation. We aim to build a fully integrated industrial chain for biosafety products, fostering a more harmonious environment and ensuring safer, healthier lives for people worldwide.
Mission
Empowering customers, relentlessly driving innovation, embracing responsibility, and fostering win-win collaboration.
Qitian Gene's Corporate Values
Values
Development Journey
DEVELOPMENT HISTORY
Honorary Qualifications
HONORS AND QUALIFICATIONS
News and Information
NEWS INFORMATION
Literature Sharing
Literature Sharing